A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease

References

• Vos T, Mathers CD. The burden of mental disorders: a comparison of methods between the Australian burden of disease studies and the Global Burden of Disease study. WHO Bull 2000; 78:427–438.
   PubMed Web of Science ®Google Scholar
• Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007; 370:851–858.
   PubMed Web of Science ®Google Scholar
• World Health Organization. The Global Burden of Disease, 2004 Update. Geneva: WHO, 2008.
   Google Scholar
• Carney RM, Rich MW, Freedland KE . Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988; 50:627–633.
   PubMed Web of Science ®Google Scholar
• Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993; 270:1819–1825.
   PubMed Web of Science ®Google Scholar
• Kawachi I, Colditz GA, Ascherio A . Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994; 89:1992–1997.
   PubMed Web of Science ®Google Scholar
• Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998; 55:580–592.
   PubMed Web of Science ®Google Scholar
• Rugulies R. Depression as a predictor for coronary heart disease. a review and meta-analysis. Am J Prev Med 2002; 23:51–61.
   PubMed Web of Science ®Google Scholar
• Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 2003; 65:201–210.
   PubMed Web of Science ®Google Scholar
• Goldston K, Baillie AJ. Depression and coronary heart disease: a review of the epidemiological evidence, explanatory mechanisms and management approaches. Clin Psychol Rev 2008; 28:288–306.
   PubMed Web of Science ®Google Scholar
• Seymour J, Benning TB. Depression, cardiac mortality and all-cause mortality. Adv Psychiatric Treatment 2009; 15:107–113.
   Google Scholar
• Schulman J, Shapiro P. Depression and cardiovascular disease: what is the correlation? Psychiatric Times 2008; 29:41.
   Google Scholar
• Penninx BW, Beekman AT, Honig A . Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001; 58:221–227.
   PubMed Web of Science ®Google Scholar
• Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002; 105:1049–1053.
   PubMed Web of Science ®Google Scholar
• Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99:2192–2217.
   PubMed Web of Science ®Google Scholar
• Thombs BD, Bass EB, Ford DE . Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 2006; 21:30–38.
   PubMed Web of Science ®Google Scholar
• Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004; 66:802–813.
   PubMed Web of Science ®Google Scholar
• Tracey KJ. The inflammatory reflex. Nature 2002; 420:853–859.
   PubMed Web of Science ®Google Scholar
• de Jonge P, Rosmalen JG, Kema IP . Psychophysiological biomarkers explaining the association between depression and prognosis in coronary artery patients: A critical review of the literature. Neurosci Biobehav Rev 2009.
   PubMedGoogle Scholar
• Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 2002; 53:897–902.
   PubMed Web of Science ®Google Scholar
• Pacher P, Kecskemeti V. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr Pharm Des 2004; 10:2463–2475.
   PubMed Web of Science ®Google Scholar
• Schulman J, Muskin P, Shapiro P. Psychiatry and cardiovascular disease. Focus 2005; 3:208–224.
   Google Scholar
• Kawakami N, Takatsuka N, Shimizu H, Ishibashi H. Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 1999; 22:1071–1076.
   PubMed Web of Science ®Google Scholar
• Golden SH, Williams JE, Ford DE . Depressive symptoms and the risk of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2004; 27:429–435.
   PubMed Web of Science ®Google Scholar
• Arroyo C, Hu FB, Ryan LM . Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care 2004; 27:129–133.
   PubMed Web of Science ®Google Scholar
• Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974; 23:105–111.
   PubMed Web of Science ®Google Scholar
• Pine DS, Goldstein RB, Wolk S, Weissman MM. The association between childhood depression and adulthood body mass index. Pediatrics 2001; 107:1049–1056.
   PubMed Web of Science ®Google Scholar
• Goodman E, Whitaker RC. A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics 2002; 110:497–504.
   PubMed Web of Science ®Google Scholar
• Vogelzangs N, Kritchevsky SB, Beekman AT . Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry 2008; 65:1386–1393.
   PubMed Web of Science ®Google Scholar
• Luppino FS, de Wit LM, Bouvy PF . Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67:220–229.
   PubMed Web of Science ®Google Scholar
• Everson-Rose SA, Meyer PM, Powell LH . Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 2004; 27:2856–2862.
   PubMed Web of Science ®Google Scholar
• Skilton MR, Moulin P, Terra JL, Bonnet F. Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry 2007; 62:1251–1257.
   PubMed Web of Science ®Google Scholar
• Malik S, Wong ND, Franklin SS . Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110:1245–1250.
   PubMed Web of Science ®Google Scholar
• Dekker JM, Girman C, Rhodes T . Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005; 112:666–673.
   PubMed Web of Science ®Google Scholar
• Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28:1769–1778.
   PubMed Web of Science ®Google Scholar
• Kaplan G, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 1993; 88:1973–1998.
   PubMed Web of Science ®Google Scholar
• Tennant C. Life stress, social support and coronary heart disease. Aust N Z J Psychiatry 1999; 33:636–641.
   PubMed Web of Science ®Google Scholar
• Segrin C. Social skills deficits associated with depression. Clin Psychol Rev 2000; 20:379–403.
   PubMed Web of Science ®Google Scholar
• DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160:2101–2107.
   PubMed Web of Science ®Google Scholar
• Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000; 160:1818–1823.
   PubMed Web of Science ®Google Scholar
• House JS, Robbins C, Metzner HL. The association of social relationships and activities with mortality: prospective evidence from the Tecumseh Community Health Study. Am J Epidemiol 1982; 116:123–140.
   PubMed Web of Science ®Google Scholar
• Berkman LF, Leo-Summers L, Horwitz RI. Emotional support and survival after myocardial infarction. A prospective, population-based study of the elderly. Ann Intern Med 1992; 117:1003–1009.
   PubMed Web of Science ®Google Scholar
• Frasure-Smith N, Lesperance F, Gravel G . Social support, depression, and mortality during the first year after myocardial infarction. Circulation 2000; 101:1919–1924.
   PubMed Web of Science ®Google Scholar
• Joutsenniemi K, Martelin T, Martikainen P, Pirkola S, Koskinen S. Living arrangements and mental health in Finland. J Epidemiol Community Health 2006; 60:468–475.
   PubMed Web of Science ®Google Scholar
• Brown MA, Munford AM, Munford PR. Behavior therapy of psychological distress in patients after myocardial infarction or coronary bypass. J Cardiopulm Rehabil 1993; 13:201–210.
   Google Scholar
• Stern MJ, Pascale L, Ackerman A. Life adjustment postmyocardial infarction: determining predictive variables. Arch Intern Med 1977; 137:1680–1685.
   PubMed Web of Science ®Google Scholar
• Breslau N, Peterson EL, Schultz LR, Chilcoat HD, Andreski P. Major depression and stages of smoking. A longitudinal investigation. Arch Gen Psychiatry 1998; 55:161–166.
   PubMed Web of Science ®Google Scholar
• Fergusson DM, Goodwin RD, Horwood LJ. Major depression and cigarette smoking: results of a 21-year longitudinal study. Psychol Med 2003; 33:1357–1367.
   PubMed Web of Science ®Google Scholar
• John U, Meyer C, Rumpf HJ, Hapke U. Self-efficacy to refrain from smoking predicted by major depression and nicotine dependence. Addict Behav 2004; 29:857–866.
   PubMed Web of Science ®Google Scholar
• Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL. Depression and the dynamics of smoking. A national perspective. JAMA 1990; 264:1541–1545.
   PubMed Web of Science ®Google Scholar
• Hall SM, Munoz RF, Reus VI, Sees KL. Nicotine, negative affect, and depression. J Consult Clin Psychol 1993; 61:761–767.
   PubMed Web of Science ®Google Scholar
• Quattrocki E, Baird A, Yurgelun-Todd D. Biological aspects of the link between smoking and depression. Harv Rev Psychiatry 2000; 8: 99–110.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ounpuu S . Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 2004; 364:937–952.
   PubMed Web of Science ®Google Scholar
• McCaffery JM, Duan QL, Frasure-Smith N . Genetic predictors of depressive symptoms in cardiac patients. Am J Med Genet B Neuropsychiatr Genet 2009; 150B:381–388.
   PubMedGoogle Scholar
• Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994; 40:288–295.
   PubMed Web of Science ®Google Scholar
• Furlong RA, Ho L, Walsh C . Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet 1998; 81:58–63.
   PubMed Web of Science ®Google Scholar
• Ogilvie AD, Battersby S, Bubb VJ . Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 1996; 347:731–733.
   PubMed Web of Science ®Google Scholar
• Caspi A, Sugden K, Moffitt TE . Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301:386–389.
   PubMed Web of Science ®Google Scholar
• Jacobs N, Kenis G, Peeters F, Derom C, Vlietinck R, van Os J. Stress-related negative affectivity and genetically altered serotonin transporter function: evidence of synergism in shaping risk of depression. Arch Gen Psychiatry 2006; 63:989–996.
   PubMedGoogle Scholar
• Eley TC, Sugden K, Corsico A . Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry 2004; 9:908–915.
   PubMed Web of Science ®Google Scholar
• Wilhelm K, Mitchell PB, Niven H . Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry 2006; 188:210–215.
   PubMed Web of Science ®Google Scholar
• Hoefgen B, Schulze TG, Ohlraun S . The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder. Biol Psychiatry 2005; 57:247–251.
   PubMed Web of Science ®Google Scholar
• Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 2005; 62:529–535.
   PubMed Web of Science ®Google Scholar
• Kaufman J, Yang BZ, Douglas-Palumberi H . Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci USA 2004; 101:17316–17321.
   PubMed Web of Science ®Google Scholar
• Zalsman G, Huang YY, Oquendo MA . Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry 2006; 163:1588–1593.
   PubMed Web of Science ®Google Scholar
• Otte C, McCaffery J, Ali S, Whooley MA. Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am J Psychiatry 2007; 164:1379–1384.
   PubMed Web of Science ®Google Scholar
• Nakatani D, Sato H, Sakata Y . Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J 2005; 150:652–658.
   PubMed Web of Science ®Google Scholar
• Ramamoorthy S, Bauman AL, Moore KR . Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 1993; 90:2542–2546.
   PubMed Web of Science ®Google Scholar
• Hoffman BJ, Mezey E, Brownstein MJ. Cloning of a serotonin transporter affected by antidepressants. Science 1991; 254:579–580.
   PubMed Web of Science ®Google Scholar
• Ramasubbu R. Serotonin transporter gene functional polymorphism: a plausible candidate gene for increased vascular risk in depression. Med Hypotheses 2003; 61:36–44.
   PubMed Web of Science ®Google Scholar
• Danesh J, Whincup P, Walker M . Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br Med J 2000; 321:199–204.
   PubMed Web of Science ®Google Scholar
• Appels A, Bar FW, Bar J, Bruggeman C, de Baets M. Inflammation, depressive symptomtology, and coronary artery disease. Psychosom Med 2000; 62:601–605.
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser JK, Glaser R. Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res 2002; 53:873–876.
   PubMed Web of Science ®Google Scholar
• Maes M, Meltzer HY, Bosmans E . Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 1995; 34:301–309.
   PubMed Web of Science ®Google Scholar
• Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 2001; 11: 203–208.
   PubMed Web of Science ®Google Scholar
• Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002; 90:1279–1283.
   PubMed Web of Science ®Google Scholar
• Bremmer MA, Beekman AT, Deeg DJ . Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 2008; 106:249–255.
   PubMed Web of Science ®Google Scholar
• Blum A, Miller H. Pathophysiological role of cytokines in congestive heart failure. Annu Rev Med 2001; 52:15–27.
   PubMedGoogle Scholar
• Alonso-Martinez JL, Llorente-Diez B, Echegaray-Agara M, Olaz-Preciado F, Urbieta-Echezarreta M, Gonzalez-Arencibia C. C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail 2002; 4:331–336.
   PubMed Web of Science ®Google Scholar
• Empana JP, Sykes DH, Luc G . Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2005; 111: 2299–2305.
   PubMedGoogle Scholar
• Tousoulis D, Davies G, Stefanadis C, Toutouzas P, Ambrose JA. Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart 2003; 89:993–997.
   PubMed Web of Science ®Google Scholar
• Dantzer R, Wollman EE, Yirmiya R. Cytokines and depression: an update. Brain Behav Immun 2002; 16:501–502.
   PubMedGoogle Scholar
• Frasure-Smith N, Lesperance F. Reflections on depression as a cardiac risk factor. Psychosom Med 2005; 67 Suppl 1:S19–25.
   PubMedGoogle Scholar
• Schins A, Tulner D, Lousberg R . Inflammatory markers in depressed post-myocardial infarction patients. J Psychiatr Res 2005; 39:137–144.
   PubMed Web of Science ®Google Scholar
• Laghrissi-Thode F, Wagner WR, Pollock BG, Johnson PC, Finkel MS. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 1997; 42:290–295.
   PubMed Web of Science ®Google Scholar
• Nemeroff CB, Musselman DL. Are platelets the link between depression and ischemic heart disease? Am Heart J 2000; 140:57–62.
   PubMed Web of Science ®Google Scholar
• O'Connor CM, Gurbel PA, Serebruany VL. Depression and ischemic heart disease. Am Heart J 2000; 140:63–69.
   PubMed Web of Science ®Google Scholar
• Ghiadoni L, Donald AE, Cropley M . Mental stress induces transient endothelial dysfunction in humans. Circulation 2000; 102: 2473–2478.
   PubMed Web of Science ®Google Scholar
• Spieker LE, Hurlimann D, Ruschitzka F . Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation 2002; 105:2817–2820.
   PubMed Web of Science ®Google Scholar
• Broadley AJ, Korszun A, Jones CJ, Frenneaux MP. Arterial endothelial function is impaired in treated depression. Heart 2002; 88:521–523.
   PubMed Web of Science ®Google Scholar
• Harris KF, Matthews KA, Sutton-Tyrrell K, Kuller LH. Associations between psychological traits and endothelial function in postmenopausal women. Psychosom Med 2003; 65:402–409.
   PubMed Web of Science ®Google Scholar
• Rajagopalan S, Brook R, Rubenfire M, Pitt E, Young E, Pitt B. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol 2001; 88:196–198, A7.
   PubMed Web of Science ®Google Scholar
• Lesperance F, Frasure-Smith N, Theroux P, Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 2004; 161:271–277.
   PubMed Web of Science ®Google Scholar
• Dale GL, Friese P, Batar P . Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 2002; 415:175–179.
   PubMed Web of Science ®Google Scholar
• De Clerck F. Effects of serotonin on platelets and blood vessels. J Cardiovasc Pharmacol 1991; 17S5:S1–5.
   Google Scholar
• Weyrich AS, Solis GA, Li KS, Tulenko TN, Santamore WP. Platelet amplification of vasospasm. Am J Physiol 1992; 263:H3 49–358.
   Google Scholar
• Arora RC, Meltzer HY. Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients. Life Sci 1989; 44: 725–734.
   PubMedGoogle Scholar
• Sheline YI, Bardgett ME, Jackson JL, Newcomer JW, Csernansky JG. Platelet serotonin markers and depressive symptomatology. Biol Psychiatry 1995; 37:442–447.
   PubMedGoogle Scholar
• Shimbo D, Child J, Davidson K . Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes. Am J Cardiol 2002; 89:331–333.
   PubMed Web of Science ®Google Scholar
• Cerrito F, Lazzaro MP, Gaudio E, Arminio P, Aloisi G. 5HT2-receptors and serotonin release: their role in human platelet aggregation. Life Sci 1993; 53:209–215.
   PubMed Web of Science ®Google Scholar
• Nemeroff CB, Knight DL, Franks J, Craighead WE, Krishnan KR. Further studies on platelet serotonin transporter binding in depression. Am J Psychiatry 1994; 151:1623–1625.
   PubMedGoogle Scholar
• Vieweg WV, Julius DA, Fernandez A . Treatment of depression in patients with coronary heart disease. Am J Med 2006; 119: 567–573.
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. ‘Vascular depression’ hypothesis. Arch Gen Psychiatry 1997; 54:915–922.
   PubMed Web of Science ®Google Scholar
• Frasure-Smith N, Lesperance F, Julien P. Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry 2004; 55:891–896.
   PubMed Web of Science ®Google Scholar
• Amin AA, Menon RA, Reid KJ, Harris WS, Spertus JA. Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels. Psychosom Med 2008; 70: 856–862.
   PubMed Web of Science ®Google Scholar
• Parker G, Gibson NA, Brotchie H, Heruc G, Rees AM, Hadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. Am J Psychiatry 2006; 163:969–978.
   PubMed Web of Science ®Google Scholar
• Hibbeln JR. Fish consumption and major depression. Lancet 1998; 351:1213.
   PubMed Web of Science ®Google Scholar
• Hibbeln JR, Salem N Jr. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 1995; 62:1–9.
   PubMed Web of Science ®Google Scholar
• Horrobin DF. A new category of psychotropic drugs: neuroactive lipids as exemplified by ethyl eicosapentaenoate (E-E). Prog Drug Res 2002; 59:171–199.
   PubMedGoogle Scholar
• Locke CA, Stoll AL. Omega-3 fatty acids in major depression. World Rev Nutr Diet 2001; 89:173–185.
   PubMedGoogle Scholar
• Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H. Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord 1996; 38:35–46.
   PubMed Web of Science ®Google Scholar
• Sontrop J, Campbell MK. Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Prev Med 2006; 42:4–13.
   PubMed Web of Science ®Google Scholar
• Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 2007; 68:1056–1061.
   PubMed Web of Science ®Google Scholar
• Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002; 159:477–479.
   PubMed Web of Science ®Google Scholar
• Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002; 59:913–919.
   PubMed Web of Science ®Google Scholar
• Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106:2747–2757.
   PubMed Web of Science ®Google Scholar
• Harris WS, Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 2004; 39: 212–220.
   PubMed Web of Science ®Google Scholar
• Bruinsma KA, Taren DL. Dieting, essential fatty acid intake, and depression. Nutr Rev 2000; 58:98–108.
   PubMed Web of Science ®Google Scholar
• Haag M. Essential fatty acids and the brain. Can J Psychiatry 2003; 48:195–203.
   PubMed Web of Science ®Google Scholar
• Iso H, Sato S, Umemura U . Linoleic acid, other fatty acids, and the risk of stroke. Stroke 2002; 33:2086–2093.
   PubMed Web of Science ®Google Scholar
• Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002; 21:495–505.
   PubMed Web of Science ®Google Scholar
• Davydov DM, Shapiro D, Cook IA, Goldstein I. Baroreflex mechanisms in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:164–177.
   PubMedGoogle Scholar
• De Meersman RE, Stein PK. Vagal modulation and aging. Biol Psychol 2007; 74:165–173.
   PubMed Web of Science ®Google Scholar
• Grippo AJ, Johnson AK. Biological mechanisms in the relationship between depression and heart disease. Neurosci Biobehav Rev 2002; 26:941–962.
   PubMed Web of Science ®Google Scholar
• Esler M, Turbott J, Schwarz R . The peripheral kinetics of norepinephrine in depressive illness. Arch Gen Psychiatry 1982; 39:295–300.
   PubMedGoogle Scholar
• Veith RC, Lewis N, Linares OA . Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry 1994; 51:411–422.
   PubMed Web of Science ®Google Scholar
• Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol 1995; 76:562–564.
   PubMed Web of Science ®Google Scholar
• Sloan RP, Shapiro PA, Bagiella E, Myers MM, Gorman JM. Cardiac autonomic control buffers blood pressure variability responses to challenge: a psychophysiologic model of coronary artery disease. Psychosom Med 1999; 61:58–68.
   PubMed Web of Science ®Google Scholar
• Esler M, Jennings G, Lambert G. Measurement of overall and cardiac norepinephrine release into plasma during cognitive challenge. Psychoneuroendocrinology 1989; 14:477–481.
   PubMed Web of Science ®Google Scholar
• Light KC, Kothandapani RV, Allen MT. Enhanced cardiovascular and catecholamine responses in women with depressive symptoms. Int J Psychophysiol 1998; 28:157–166.
   PubMed Web of Science ®Google Scholar
• Sheffield D, Krittayaphong R, Cascio WE . Heart rate variability at rest and during mental stress in patients with coronary artery disease: differences in patients with high and low depression scores. Int J Behav Med 1998; 5:31–47.
   PubMedGoogle Scholar
• Hughes JW, Stoney CM. Depressed mood is related to high-frequency heart rate variability during stressors. Psychosom Med 2000; 62:796–803.
   PubMed Web of Science ®Google Scholar
• Hamer M, Tanaka G, Okamura H, Tsuda A, Steptoe A. The effects of depressive symptoms on cardiovascular and catecholamine responses to the induction of depressive mood. Biol Psychol 2007; 74:20–25.
   PubMed Web of Science ®Google Scholar
• Scalco AZ, Rondon MU, Trombetta IC . Muscle sympathetic nervous activity in depressed patients before and after treatment with sertraline. J Hypertens 2009; 27:2429–2436.
   PubMed Web of Science ®Google Scholar
• Barton DA, Dawood T, Lambert EA . Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens 2007; 25:2117–2124.
   PubMed Web of Science ®Google Scholar
• Lambert EA, Schlaich MP. Reduced sympathoneural responses to the cold pressor test in individuals with essential hypertension and in those genetically predisposed to hypertension. No support for the ‘pressor reactor’ hypothesis of hypertension development. Am J Hypertens 2004; 17:863–868.
   PubMedGoogle Scholar
• Grassi G, Seravalle G, Cattaneo BM . Sympathetic activation in obese normotensive subjects. Hypertension 1995; 25:560–563.
   PubMed Web of Science ®Google Scholar
• Lambert GW, Straznicky NE, Lambert EA, Dixon JB, Schlaich MP. Sympathetic nervous activation in obesity and the metabolic syndrome: causes, consequences and therapeutic implications. Pharmacol Ther 2010; 126:159–172.
   PubMed Web of Science ®Google Scholar
• Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens 2004; 22:2363–2369.
   PubMed Web of Science ®Google Scholar
• Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab 2005; 90:5998–6005.
   PubMed Web of Science ®Google Scholar
• Lee ZS, Critchley JA, Tomlinson B . Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese. Metabolism 2001; 50:135–143.
   PubMedGoogle Scholar
• Brunner EJ, Hemingway H, Walker BR . Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case–control study. Circulation 2002; 106:2659–2665.
   PubMed Web of Science ®Google Scholar
• Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997; 96: 3423–3429.
   PubMed Web of Science ®Google Scholar
• La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351:478–484.
   PubMed Web of Science ®Google Scholar
• Vingerhoets A. Psychosocial Stress: An Experimental Approach. Life Events, Coping, and Psychobiological Functioning. Groningen, Netherlands: Swets & Zeitlinger, 1985.
   Google Scholar
• Selye H. The Stress of Life. New York: McGraw-Hill, 1956.
   Google Scholar
• Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1). N Engl J Med 1988; 319:348–353.
   PubMed Web of Science ®Google Scholar
• Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2). N Engl J Med 1988; 19:413–420.
   Google Scholar
• Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992; 267:1244–1252.
   PubMed Web of Science ®Google Scholar
• Carroll, Curtis GC, Mendels J. Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. Arch Gen Psychiatry 1976; 33:1039–1044.
   PubMed Web of Science ®Google Scholar
• Asnis GM, Halbreich U, Ryan ND . The relationship of the dexamethasone suppression test (1 mg and 2 mg) to basal plasma cortisol levels in endogenous depression. Psychoneuroendocrinology 1987; 12:295–301.
   PubMed Web of Science ®Google Scholar
• Coryell W, Schlesser M. The dexamethasone suppression test and suicide prediction. Am J Psychiatry 2001; 158:748–753.
   PubMed Web of Science ®Google Scholar
• Nemeroff CB, Widerlov E, Bissette G . Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984; 226:1342–1344.
   PubMed Web of Science ®Google Scholar
• Banki CM, Bissette G, Arato M, O'Connor L, Nemeroff CB. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am J Psychiatry 1987; 144:873–877.
   PubMed Web of Science ®Google Scholar
• Banki CM, Karmacsi L, Bissette G, Nemeroff CB. CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse. Eur Neuropsychopharmacol 1992; 2:107–113.
   PubMedGoogle Scholar
• Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ, Swaab DF. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 1995; 152: 1372–1376.
   PubMed Web of Science ®Google Scholar
• Sirinathsinghji DJ, Rees LH, Rivier J, Vale W. Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Nature 1983; 305:232–235.
   PubMedGoogle Scholar
• Glowa JR, Gold PW. Corticotropin releasing hormone produces profound anorexigenic effects in the rhesus monkey. Neuropeptides 1991; 18:55–61.
   PubMed Web of Science ®Google Scholar
• Brown MR, Fisher LA, Spiess J, Rivier C, Rivier J, Vale W. Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology 1982; 111:928–931.
   PubMed Web of Science ®Google Scholar
• Forbes LM, Chaney RH. Cardiovascular changes during acute depression. Psychosomatics 1980; 21:472–477.
   PubMedGoogle Scholar
• Carney RM, Freedland KE, Rich MW, Smith LJ, Jaffe AS. Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. Am J Med 1993; 95:23–28.
   PubMed Web of Science ®Google Scholar
• Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001; 104:1477–1482.
   PubMed Web of Science ®Google Scholar
• Carney RM, Rich MW, teVelde A, Saini J, Clark K, Freedland KE. The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. J Psychosom Res 1988; 32:159–164.
   PubMed Web of Science ®Google Scholar
• Dyer AR, Persky V, Stamler J . Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980; 112: 736–749.
   PubMed Web of Science ®Google Scholar
• Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113:1489–1494.
   PubMed Web of Science ®Google Scholar
• Palatini P, Julius S. Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens 1997; 11S1:S19–27.
   Google Scholar
• Gordon D, Guyton JR, Karnovsky MJ. Intimal alterations in rat aorta induced by stressful stimuli. Lab Invest 1981; 45:14–27.
   PubMedGoogle Scholar
• Troxler RG, Sprague EA, Albanese RA, Fuchs R, Thompson AJ. The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography. Atherosclerosis 1977; 26:151–162.
   PubMed Web of Science ®Google Scholar
• Kaplan J, Pettersson K, Manuck SB, Olsson G. Role of sympathoadrenal medullary activation in the initiation and progression of atherosclerosis. Circulation 1991; 84:VI23–132.
   PubMed Web of Science ®Google Scholar
• Colao A, Pivonello R, Spiezia S . Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 1999; 84:2664–2672.
   PubMed Web of Science ®Google Scholar
• Goldberg AD, Becker LC, Bonsall R . Ischemic, hemodynamic, and neurohormonal responses to mental and exercise stress. Experience from the Psychophysiological Investigations of Myocardial Ischemia study (PIMI). Circulation 1996; 94:2402–2409.
   PubMed Web of Science ®Google Scholar
• Krantz DS, Helmers KF, Bairey CN, Nebel LE, Hedges SM, Rozanski A. Cardiovascular reactivity and mental stress-induced myocardial ischemia in patients with coronary artery disease. Psychosom Med 1991; 53:1–12.
   PubMed Web of Science ®Google Scholar
• Resstel LB, Fernandes KB, Correa FM. Medial prefrontal cortex modulation of the baroreflex parasympathetic component in the rat. Brain Res 2004; 1015:136–144.
   PubMed Web of Science ®Google Scholar
• Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 2000; 48:766–777.
   PubMed Web of Science ®Google Scholar
• Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148:209–214.
   PubMed Web of Science ®Google Scholar
• Berntson GG, Norman GJ, Hawkley LC, Cacioppo JT. Cardiac autonomic balance versus cardiac regulatory capacity. Psychophysiology 2008; 45:643–652.
   PubMed Web of Science ®Google Scholar
• Thayer JF, Sternberg E. Beyond heart rate variability: vagal regulation of allostatic systems. Ann N Y Acad Sci 2006; 1088:361–372.
   PubMed Web of Science ®Google Scholar
• Goldberger AL, West BJ. Applications of nonlinear dynamics to clinical cardiology. Ann N Y Acad Sci 1987;504:195–213.
   PubMed Web of Science ®Google Scholar
• Carney RM, Blumenthal JA, Stein PK . Depression, heart rate variability, and acute myocardial infarction. Circulation 2001; 104: 2024–2028.
   PubMed Web of Science ®Google Scholar
• Rottenberg J. Cardiac vagal control in depression: a critical analysis. Biol Psychol 2007; 74:200–211.
   PubMed Web of Science ®Google Scholar
• Higgins CB, Vatner SF, Braunwald E. Parasympathetic control of the heart. Pharmacol Rev 1973; 25:119–155.
   PubMed Web of Science ®Google Scholar
• Berntson GG, Cacioppo JT, Quigley KS. Autonomic determinism: the modes of autonomic control, the doctrine of autonomic space, and the laws of autonomic constraint. Psychol Rev 1991; 98:459–487.
   PubMed Web of Science ®Google Scholar
• Curtis BM, O'Keefe JH Jr. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc 2002; 77:45–54.
   PubMed Web of Science ®Google Scholar
• Huikuri HV, Makikallio TH. Heart rate variability in ischemic heart disease. Auton Neurosci 2001; 90:95–101.
   PubMed Web of Science ®Google Scholar
• Tsuji H, Larson MG, Venditti FJ Jr . Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996; 94:2850–2855.
   PubMed Web of Science ®Google Scholar
• Pedretti R, Etro MD, Laporta A, Sarzi Braga S, Caru B. Prediction of late arrhythmic events after acute myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained monomorphic ventricular tachycardia. Am J Cardiol 1993; 71:1131–1141.
   PubMed Web of Science ®Google Scholar
• Bigger JT Jr, Steinman RC, Rolnitzky LM, Fleiss JL, Albrecht P, Cohen RJ. Power law behavior of RR-interval variability in healthy middle-aged persons, patients with recent acute myocardial infarction, and patients with heart transplants. Circulation 1996; 93:2142–2151.
   PubMed Web of Science ®Google Scholar
• Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59:256–262.
   PubMed Web of Science ®Google Scholar
• Malik M, Farrell T, Camm AJ. Circadian rhythm of heart rate variability after acute myocardial infarction and its influence on the prognostic value of heart rate variability. Am J Cardiol 1990; 66:1049–1054.
   PubMed Web of Science ®Google Scholar
• Farrell TG, Bashir Y, Cripps T . Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol 1991; 18:687–697.
   PubMed Web of Science ®Google Scholar
• Casolo GC, Stroder P, Signorini C . Heart rate variability during the acute phase of myocardial infarction. Circulation 1992; 85:2073–2079.
   PubMed Web of Science ®Google Scholar
• Bigger JT Jr, Kleiger RE, Fleiss JL, Rolnitzky LM, Steinman RC, Miller JP. Components of heart rate variability measured during healing of acute myocardial infarction. Am J Cardiol 1988; 61: 208–215.
   PubMed Web of Science ®Google Scholar
• Dekker JM, Crow RS, Folsom AR . Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study, Atherosclerosis Risk In Communities. Circulation 2000; 102: 1239–1244.
   PubMed Web of Science ®Google Scholar
• Dekker JM, Schouten EG, Klootwijk P, Pool J, Swenne CA, Kromhout D. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. Am J Epidemiol 1997; 145:899–908.
   PubMed Web of Science ®Google Scholar
• Goldberger AL, Findley LJ, Blackburn MR, Mandell AJ. Nonlinear dynamics in heart failure: implications of long-wavelength cardiopulmonary oscillations. Am Heart J 1984; 107:612–615.
   PubMed Web of Science ®Google Scholar
• Myers GA, Martin GJ, Magid NM . Power spectral analysis of heart rate variability in sudden cardiac death: comparison to other methods. IEEE Trans Biomed Eng 1986; 33:1149–1156.
   PubMed Web of Science ®Google Scholar
• Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA 2003; 290:932–940.
   PubMed Web of Science ®Google Scholar
• Noorbakhsh F, Overall CM, Power C. Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology. Trends Neurosci 2009; 32:88–100.
   PubMed Web of Science ®Google Scholar
• Alm E, Arkin AP. Biological networks. Curr Opin Struct Biol 2003; 13:193–202.
   PubMed Web of Science ®Google Scholar
• Liljeros F, Edling CR, Amaral LA, Stanley HE, Aberg Y. The web of human sexual contacts. Nature 2001; 411:907–908.
   PubMed Web of Science ®Google Scholar
• Newman ME. The structure of scientific collaboration networks. Proc Natl Acad Sci USA 2001; 98:404–409.
   PubMed Web of Science ®Google Scholar
• Barabasi AL, Jeong H, Ravasz R, Neda Z, Vicsek T, Schubert A. On the topology of the scientific collaboration networks. Physica A 2002; 311:590.
   Web of Science ®Google Scholar
• Faloutsos M, Faloutsos P, Faloutsos C. On power-law relationships of the Internet topology. Comput Commu Rev 1999; 29:251–262.
   Google Scholar
• Albert R, Jeong H, Barabasi AL. Diameter of the World Wide Web. Nature 1999; 401:130–131.
   Web of Science ®Google Scholar
• Kitano H. Systems biology: a brief overview. Science 2002; 295: 1662–1664.
   PubMed Web of Science ®Google Scholar
• Nikolsky Y, Nikolskaya T, Bugrim A. Biological networks and analysis of experimental data in drug discovery. Drug Discov Today 2005; 10:653–662.
   PubMed Web of Science ®Google Scholar
• Dunne JA, Williams RJ, Martinez ND. Food-web structure and network theory: the role of connectance and size. Proc Natl Acad Sci USA 2002; 99:12917–12922.
   PubMed Web of Science ®Google Scholar
• Williams RJ, Martinez ND. Simple rules yield complex food webs. Nature 2000; 404:180–183.
   PubMed Web of Science ®Google Scholar
• Barabasi AL, Oltvai ZN. Network biology: understanding the cell's functional organization. Nat Rev Genet 2004;5:101–113.
   PubMed Web of Science ®Google Scholar
• Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL. Hierarchical organization of modularity in metabolic networks. Science 2002; 297:1551–1555.
   PubMed Web of Science ®Google Scholar